Patents by Inventor Andreas Berg Storsve

Andreas Berg Storsve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA
    Publication number: 20230364157
    Abstract: The present invention provides compositions comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy, particularly when administered systemically. This invention further relates to a modified krill oil composition enriched in LPC-DHA and LPC-EPA, methods of making and methods of using to treat neurological and ocular disorders.
    Type: Application
    Filed: July 26, 2023
    Publication date: November 16, 2023
    Inventors: Finn Myhren, Petter-Arnt Hals, Nils Hoem, Andreas Berg Storsve, Papasani V. Subbaiah, Poorna Yalagala, Sugasini Dhavamani, Leon Tai
  • Method of treating eye diseases with krill oil
    Patent number: 11744864
    Abstract: The present invention provides compositions comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy, particularly when administered systemically. This invention further relates to a modified krill oil composition enriched in LPC-DHA and LPC-EPA, methods of making and methods of using to treat neurological and ocular disorders.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: September 5, 2023
    Assignee: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Finn Myhren, Petter-Arnt Hals, Nils Hoem, Andreas Berg Storsve, Papasani V. Subbaiah, Poorna Yalagala, Sugasini Dhavamani, Leon Tai
  • PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY
    Publication number: 20230038627
    Abstract: The present invention relates to pharmaceutical formulations of phospholipids, and in particular pharmaceutical formulations which are administered intravascularly such as intravenously. In particular, the present invention provides pharmaceutical compositions for intravascular administration comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy.
    Type: Application
    Filed: June 21, 2020
    Publication date: February 9, 2023
    Inventors: Lotte SKOLEM, Finn MYHREN, Nils HOEM, Petter-Arnt HALS, Andreas BERG STORSVE, Armend Gazmeno HÅTI
  • KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA
    Publication number: 20210308193
    Abstract: The present invention provides compositions comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy, particularly when administered systemically. This invention further relates to a modified krill oil composition enriched in LPC-DHA and LPC-EPA, methods of making and methods of using to treat neurological and ocular disorders.
    Type: Application
    Filed: March 31, 2021
    Publication date: October 7, 2021
    Inventors: Finn Myhren, Petter-Arnt Hals, Nils Hoem, Andreas Berg Storsve, Papasani V. Subbaiah, Poorna Yalagala, Sugasini Dhavamani, Leon Tai